Back to News
Market Impact: 0.2

MercadoLibre: Buyer Loyalty Is Ramping Up, Margin Pains Are Merely Temporary

Company FundamentalsAnalyst InsightsConsumer Demand & RetailCorporate EarningsMarket Technicals & Flows
MercadoLibre: Buyer Loyalty Is Ramping Up, Margin Pains Are Merely Temporary

Analyst reiterates a “Buy” rating on MercadoLibre (MELI), arguing the recent ~20% dip is a compelling entry point despite near-term headwinds. The stock trades at a ~20x adjusted EBITDA premium, which the analyst says is supported by MELI’s dominant market position and 50% y/y revenue growth in Q2.

Analysis

The market is still paying for MELI’s option value as the dominant infrastructure layer in underpenetrated markets, not just for near-term earnings. That matters because scale in logistics, payments, and merchant acquisition creates a flywheel that smaller regional platforms cannot match once the company reaccelerates marketing spend after a drawdown. The key second-order effect is that weaker competitors will likely be forced into margin-squeezing promotions or retreat into niches, which should further entrench MELI’s take-rate and ecosystem stickiness over the next 6-18 months.

The near-term risk is not the business model but the multiple: at this valuation, any sign that growth is normalizing faster than expected can compress the EBITDA premium quickly, especially if FX, credit, or consumer softness leaks into forward guidance. The next 1-3 months matter most around the next print and management commentary on unit economics; the market will care more about incremental margin conversion and credit performance than headline revenue growth. What would falsify the bull case is a sustained slowdown in GMV/TPV growth, worsening delinquency trends, or evidence that reinvestment is no longer converting into higher lifetime value.

The contrarian view is that the recent pullback may actually be insufficient if investors are underestimating how long the premium can stay high for a scarce EM compounder. But if the rotation into value persists, MELI could remain a funding source for crowded growth portfolios rather than a standalone re-rating story. My base case is to buy weakness only if the next catalyst confirms operating leverage; otherwise the stock can languish despite strong fundamentals.

More News